Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune ...

The plaintiffs in the $2.35 million award from last week, Douglas Muhlbauer and related entities, sued Stifel Nicolaus last ...

Palo Alto Networks (NASDAQ:PANW) was in the spotlight on Thursday as research firm Stifel said its checks into the ...

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

A lawyer in the case says his legal team was able to present text messages showing a Stifel wealth manager had been touting complex structured notes as low-risk investments.

Crossmark Global Holdings Inc. raised its holdings in Stifel Financial Corp. (NYSE:SF – Free Report) by 12.8% in the third ...

Stifel Nicolaus analyst Jeffrey Stantial reiterated a Buy rating on Gambling.com (GAMB – Research Report) today and set a price target of ...

Comedians Patton Oswalt and Tig Notaro co-headline a show at Stifel Theater for St. Louis' Flyover Comedy Festival on Nov. 15 ...

today announced that management will present an update on the Company’s business at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 9:45 a.m. Eastern Time in NYC.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will present at the Stifel 2024 Healthcare ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the ...